Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
ID: 352883Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352883

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-007.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)," aimed at supporting small businesses in developing innovative solutions to enhance minority health and address health disparities. Eligible applicants, specifically U.S.-based small business concerns, are invited to submit Small Business Technology Transfer (STTR) grant applications that propose effective, affordable, and culturally acceptable technologies, products, or services targeting NIH-defined populations experiencing health disparities. This initiative is crucial for fostering healthcare innovations that empower communities and improve access to quality healthcare, aligning with NIH's mission to promote health equity. Applications are due starting May 10, 2024, with the final deadline on December 9, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-007.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-MD-24-007-Full-Announcement.html
    RFA-MD-24-007.html
    The Department of Health and Human Services issued a Notice of Funding Opportunity (NOFO) for Small Business Technology Transfer (STTR) grants aimed at improving minority health and eliminating health disparities. The National Institutes of Health (NIH), specifically the National Institute on Minority Health and Health Disparities (NIMHD) and other institutes, are participating in this initiative. The funding invites U.S.-based small business concerns to propose technologies, services, or products that are effective, affordable, and culturally acceptable for underrepresented populations. Key dates include a posting date of March 8, 2024, with application due dates starting May 10, 2024, and lasting through December 9, 2026. Eligible applicants need to adhere to specific application instructions and are encouraged to engage community needs in their proposals. The funding seeks to support early-stage investments in healthcare innovations that empower communities and reduce barriers related to healthcare access, affordability, and quality. Overall, the program is designed to address critical health issues and facilitate research that leads to scalable solutions for health disparities, aligning with the NIH’s mission to promote health equity among diverse populations.
    Similar Opportunities
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" under the Small Business Innovation Research (SBIR) program (R43/R44). This initiative invites Small Business Concerns (SBCs) to develop improved clinical diagnostics that address health disparities caused by existing clinical laboratory assays and point-of-care devices, particularly those that do not adequately consider diverse patient populations. The program aims to foster advancements that enhance health outcomes for historically underrepresented groups by encouraging applicants to identify specific disparities and propose innovative solutions. Applications will be accepted starting March 5, 2024, with a close date of January 5, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-158.html.
    Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Addressing Health Inequities in Clinical Diagnostics" grant, aimed at encouraging small businesses to develop innovative clinical diagnostic tools that address health disparities. Applicants are required to identify specific issues within existing clinical diagnostics that contribute to health inequities, particularly affecting underrepresented populations, and propose viable solutions to enhance equitable access to quality healthcare. This funding opportunity, which falls under the R41/R42 grant mechanism, does not support clinical trials and emphasizes the importance of stakeholder engagement from health disparity populations. Interested applicants can find more information and submit their proposals by the ongoing deadlines, with the final submission date set for January 5, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-157.html.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) grant applications, inviting eligible U.S. small businesses to submit proposals that include at least one clinical trial. This funding opportunity aims to support research and development projects that align with the scientific missions of participating NIH Institutes and Centers, emphasizing the importance of innovation in health-related technologies. Eligible applicants must be U.S.-based small businesses with majority ownership by U.S. citizens or resident aliens, and the grants provide funding caps of up to $306,872 for Phase I and $2,045,816 for Phase II projects. Interested parties should note that the application deadline is April 5, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Community Level Interventions to Improve Minority Health and Reduce Health Disparities" (R01 - Clinical Trial Optional), aimed at supporting research that develops and tests community-level interventions to enhance minority health and mitigate health disparities. Applicants are encouraged to form collaborative partnerships with community organizations and must focus on innovative, sustainable initiatives that address health disparities through community-level determinants, employing a conceptual model to connect interventions with health outcomes. The grant provides up to $1 million in direct costs per year for a project duration of up to five years, with applications due by January 7, 2027. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-231.html.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) Grant Applications, inviting eligible U.S. small businesses to submit proposals for innovative projects that align with NIH's research and development mission. This funding opportunity, identified as PA-24-247, specifically excludes clinical trials and aims to foster collaboration between small businesses and research institutions to advance technology development in health-related fields. Eligible applicants must be for-profit small businesses based in the U.S., with budget limits set at $306,872 for Phase I and $2,045,816 for Phase II awards. The application deadline is April 5, 2025, with an initial submission date of September 5, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities," aimed at supporting research initiatives that utilize health IT to improve healthcare access and outcomes for populations experiencing health disparities in the U.S. This grant, categorized under the R01 Research Project Grant, seeks to investigate the impact of health IT on health equity, particularly focusing on vulnerable groups such as racial and ethnic minorities, socioeconomically disadvantaged individuals, and sexual and gender minorities. The initiative emphasizes the importance of robust research methodologies, including clinical trials and comparative effectiveness studies, to explore areas such as digital health interventions and telehealth policies. Interested applicants can find more details and guidelines on eligibility and submission deadlines at the provided NIH link, with applications due by May 7, 2025. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities," aimed at supporting intervention research to improve health outcomes among minority populations affected by health disparities. The initiative seeks projects that investigate the influence of structural racism and discrimination on health determinants, promote multidisciplinary collaboration, and utilize diverse data sources for comprehensive analysis. With a funding ceiling of $500,000, the application deadline is set for January 7, 2026, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.